Welcome to CDC stacks | Asymmetric Type F Botulism with Cranial Nerve Demyelination - 23621 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Asymmetric Type F Botulism with Cranial Nerve Demyelination
Filetype[PDF-311.39 KB]


Details:
No Related Documents.
You May Also Like:
  1. Acute Flaccid Paralysis and West Nile Virus Infection
    Personal Author:
    Sejvar, James J.; Leis, A. Arturo; Stokic, Dobrivoje S.; Van Gerpen, Jay A.; Marfin, Anthony A.; Webb, Risa; Haddad, Maryam B.; Tierney, Bruce C.; Slavinski, Sally A.; Polk, Jo Lynn; Dostrow, Victor; Winkelmann, Michael; Petersen, Lyle R.;
    Published:
    Jul 2003
    Source:
    Emerg Infect Dis. 9(7):788-793.
    Description:
    Acute weakness associated with West Nile virus (WNV) infection has previously been attributed to a peripheral demyelinating process (Guillain-Barré syndrome); however, the exact etiology of this acute flaccid paralysis has not been systematically as...
    File Type:
    Filetype[PDF - 187.51 KB]
  2. Postmortem Findings in Patient with Guillain-Barré Syndrome and Zika Virus Infection
    Personal Author:
    Dirlikov, Emilio; Torres, José V.; Martines, Roosecelis Brasil; Reagan-Steiner, Sarah; Pérez, George Venero; Rivera, Aidsa; Major, Chelsea; Matos, Desiree; Muñoz-Jordan, Jorge; Shieh, Wun-Ju; Zaki, Sherif R.; Sharp, Tyler M.;
    Published:
    Jan 2018
    Source:
    Emerg Infect Dis. 24(1):114-117.
    Description:
    Postmortem examination results of a patient with Guillain-Barré syndrome and confirmed Zika virus infection revealed demyelination of the sciatic and cranial IV nerves, providing evidence of the acute demyelinating inflammatory polyneuropathy Guilla...
    File Type:
    Filetype[PDF - 1.20 MB]
  3. Coming Soon
    Safety and Improved Clinical Outcomes in Patients Treated With New Equine-Derived Heptavalent Botulinum Antitoxin
    Personal Author:
    Yu, Patricia A.; Lin, Neal H.; Mahon, Barbara E.; Sobel, Jeremy; Yu, Yon; Mody, Rajal K.; Gu, Weidong; Clements, Jennifer; Kim, Hye-Joo; Rao, Agam K.;
    Published:
    Dec 27 2017
    Source:
    Clin Infect Dis. 66(Suppl 1):S57-S64.
    Description:
    Background : Botulism is a rare, life-threatening paralytic illness. Equine-derived heptavalent botulinum antitoxin (HBAT), the only currently available treatment for noninfant botulism in the United States, was licensed in 2013. No reports have syst...
    Public Access
    Available on:
    December 27, 2018
  4. Botulism mortality in the USA, 1975–2009
    Personal Author:
    Jackson, Kelly A.; Mahon, Barbara E.; Copeland, John; Fagan, Ryan P.;
    Published:
    Aug 04 2016
    Source:
    Botulinum J. 3(1):6-17.
    Description:
    Botulism had mortality rates >60% before the 1950s. We reviewed confirmed botulism cases in the USA during 1975-2009 including infant, foodborne, wound, and other/unknown acquisition categories, and calculated mortality ratios. We created a mu...
    File Type:
    Filetype[PDF - 117.23 KB]
  5. Neuroinvasion by Mycoplasma pneumoniae in Acute Disseminated Encephalomyelitis
    Personal Author:
    Stamm, Bernhard; Moschopulos, Michael; Hungerbuehler, Hansjoerg; Guarner, Jeannette; Genrich, Gillian L.; Zaki, Sherif R.;
    Published:
    Apr 2008
    Source:
    Emerg Infect Dis. 14(4):641-643.
    Description:
    We report the autopsy findings for a 45-year-old man with polyradiculoneuropathy and fatal acute disseminated encephalomyelitis after having Mycoplasma pneumoniae pneumonia. M. pneumoniae antigens were demonstrated by immunohistochemical analysis of ...
    File Type:
    Filetype[PDF - 235.70 KB]